Image

Global microRNA Reverse Transcription Market - Industry Trends and Forecast to 2029

Healthcare

Image

Global microRNA Reverse Transcription Market - Industry Trends and Forecast to 2029

  • Healthcare
  • Published Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 8
  • No of Figures: 42

Global microRNA Reverse Transcription Market, By Product Type  (Instruments, Kits and Reagents, Consumables), Services ( Sample Collection, Other Services), Method (Reverse Transcription & qPCR), Application (Cancer, Kidney Disease, Neurological Disease, Cardiovascular Disease, Others), End User (Academic and Research Institutes, Biopharmaceutical Companies,  Contract Research Organizations, Diagnostic Centers) Industry Trends and Forecast to 2029.

microRNA Reverse Transcription Market

Global microRNA Reverse Transcription Market Analysis and Insights

MicroRNA are small endogenous RNA that regulates gene expression post-transcriptionally. MicroRNA are abundantly found in the mammalian types and target approximately 60% of the genes of humans and other mammals. MicroRNA reverse transcription is a crucial regulator of gene expression and a promising candidate for biomarker development.

A single microRNA can target hundreds of mRNAs and influence the expression of many genes. Further, microRNA reverse transcription involved in many allergies’ diseases including eosinophilic esophagitis, asthma and many others which is expected to increase the demand for microRNA reverse transcription. Current methodologies used for microRNA reverse transcription such as RNA-sequencing, microarrays and quantitative PCR are expected to boost the market growth.

Increasing prevalence of cancer, neurological disorder and others are expected to drive the microRNA reverse transcription market. In addition, the microRNA reverse transcription market is expected to rise exponentially due to further development in genomics technologies and computational approaches. Further, therapeutics demonstration in preclinical studies using these molecules is anticipated to increase the R&D investment in the coming years.

Also, there are various kits available such as the TaqMan, microRNA reverse transcriptase is specifically designed to generate specific cDNA, for the use with the TaqMan microRNA assays is also expected to increase the growth of microRNA reverse transcriptase market. This increase in the demand for microRNA reverse transcription has encouraged the key market players to implement newer technologies and strategies to improve the devices in the respective categories through product launches, acquisition, strategies and agreements.

The global microRNA reverse transcription market is supportive and aims to reduce the progression of the cancer, neurological disease. Data bridge market research analyses that global microRNA reverse transcription market will grow at a CAGR of 16.4% during the forecast period of 2022 to 2029.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Pricing in USD

Segments Covered

By Product Type  (Instruments, Kits and Reagents, Consumables), By Services ( Sample Collection, Other Services), By Reverse Transcription & qPCR), Application (Cancer, Kidney Disease, Neurological Disease, Cardiovascular Disease, Others), By End User (Academic and Research Institutes, Biopharmaceutical Companies,  Contract Research Organizations, Diagnostic Centers)

Market Players Covered

Thermofisher Scientific Inc., Agilent, Illumina, Inc., Merck KgaA, QIAGEN, Bio-Rad Laboratories, Inc., MiRXES Pte Ltd., Abcam plc, Takara Bio Inc., Quantabio, Horizon Discovery Ltd., NanoString., BioGenex, SeqMatic LLC, GenoSensor, LLC, OriGene Technologies, Inc., System Biosciences, LLC. , HTG Molecular Diagnostics, Inc., GeneCopoeia, Inc., New England Biolabs, Miltenyi Biotec and/or its affiliates, Applied Biological Materials Inc. (abm), Norgen Biotek Corp., Nanjing Vazyme Biotech Co.,Ltd. 

Global microRNA Reverse Transcription Market

Drivers

  • Increasing Prevalence of Cancer and Neurological Disorder

MicroRNA reverse transcription is used for biomarkers in cancer through mediated intercellular communication in neurology for the diagnosis and prognosis of alzheimer’s disease. MicroRNA reverse transcription could also be used in other fields like cardiology, as a faster and more accurate means of diagnosis for acute cardiovascular disease or heart failure and in the case of infectious diseases for the diagnosis of sepsis. Consequently, expression profiling of microRNA in human cancers correlates with cancer detection, staging, progression, and response to therapies, which boosts the microRNA reverse transcription market.

  • Increasing Increase in the Early Diagnosis Rate

With the increase in the successful diagnosis of chronic disease including cancer, anemia, type two diabetes, and others, improved health care professionals and regular training sessions for the professionals for conducting tests accounted for the improvement of diagnosis rate across the globe. Healthcare IT also has the potential, and they are putting in efforts that enhance the rate of diagnosis seeking, and they can also reduce the diagnostics errors. It also helps in detecting the risks associated with the diagnostic process and helps determine the range of the problem. Healthcare IT vendors also share and conduct to share the user experiences. This will help evaluate the consequences of the diagnostic errors, which is helping in improving the rate of diagnosis across various regions of the world. several associations and organizations are taking initiatives to spread awareness about new advanced microRNA sequencing products and technology.

Opportunities

  • Rise in Government Funding for Healthcare

Including government, federations, and major market players create opportunities across developing countries. These initiatives by the players and government are helping the users reach out for taking advantage of the policies made for low-income and developing nations and making them aware of the diseases that are preventable if diagnosed earlier.

Restraints/Challenges

However, modern technology microRNA reverse transcription devices lead to the high cost of treatment. The kits require a huge cost for the development process. As the materials need to be sourced and require raw material, they should meet different regulations and others that add up the products' cost. Additionally, the process is time-consuming as it needs sufficient time to fully mature before bringing in the market for use.

Furthermore, any changes that must be re-verified will impact time. The growing developments demanded an effective investment for successful operations and a project risk management plan. The establishment of R&D for conducting research entails high cost, which leads to expensive point of care devices.  Thus, this factor is acting as a major restrain for the market.

Global microRNA reverse transcription market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on microRNA reverse transcription market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

MicroRNA are small endogenous RNA that regulates gene expression post-transcriptionally. MicroRNA are abundantly found in the mammalian types and target approximately 60% of the genes of humans and other mammals. MicroRNA reverse transcription is a crucial regulator of gene expression and a promising candidate for biomarker development.

A single microRNA can target hundreds of mRNAs and influence the expression of many genes. Further, microRNA reverse transcription involved in many allergies’ diseases including eosinophilic esophagitis, asthma and many others which is expected to increase the demand for microRNA reverse transcription. Current methodologies used for microRNA reverse transcription such as RNA-sequencing, microarrays and quantitative PCR are expected to boost the market growth.

Global microRNA reverse transcription market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Post COVID-19 Impact on Global microRNA Reverse Transcription Market

The COVID-19 has negatively affected the healthcare market and also, covid-19 pandemic is expected to leave a long lasting impact in the global microRNA reverse transcription market. The outbreak of the virus forced the general citizens to deal with the virus and its management. This virus has greatly affected the economic sector. The healthcare industry is set to experience a few structural changes in 2022 due to the increasing prevalence of infectious diseases.

Increase in geriatric population and diseases have driven the overall growth of global microRNA reverse transcription market. However, increase in cost in diagnostic devices is expected to hinder the market growth.

Recent Development

  • In September 2021, Bio-Rad Laboratories, Inc. announced the partnership with Seegene, Inc., a global leader in multiplex molecular diagnostics, for the clinical development and commercialization of infectious disease molecular diagnostic products. This have increased company’s product portfolio.
  • In 2020, Thermo Fisher Scientific Inc., throughout the pandemic, they’ve worked closely with the highest levels of governments and healthcare institutions around the world, as well as with the pharmaceutical and biotech industry to support efforts in research, diagnostic testing, development and production.

microRNA Reverse Transcription Market

Global microRNA Reverse Transcription Market

The global microRNA reverse transcription market based on product type, services, method, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product Type

  • Instruments
  • Kits and Reagents
  • Consumables

On the basis of product type, the global microRNA reverse transcription market is segmented into Instruments, kits and reagents, consumable.

Services

  • Sample Collection
  • Other Services

On basis of by services, the global microRNA reverse transcription market is segmented into sample collection, other services.

Method

  • Reverse Trnscription
  • qPCR

On the basis of method, the global microRNA reverse transcription market is segmented into by Reverse Transcription & qPCR.

Application

  • Cancer
  • Kidney Disease
  • Neurological Disease
  • Cardiovascular Disease
  • Others

On the basis of by application , the global microRNA reverse transcription market is segmented into cancer, kidney disease, neurological disease, cardiovascular disease, others.

End User

  • Academic And Research Institutes
  • Biopharmaceutical Companies
  • Contract Research Organizations
  • Diagnostic Centers

On the basis of by end user , the global microRNA reverse transcription market is segmented into  academic and research institutes, biopharmaceutical companies,  contract research organizations, diagnostic centers.

Competitive Landscape and Global MicroRNA Reverse Transcription Market Share Analysis

The global microRNA reverse transcription market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on global microRNA reverse transcription market.

Some of the key players operating in the global microRNA reverse transcription market are Thermofisher Scientific Inc., Agilent, Illumina, Inc., Merck KgaA, QIAGEN, Bio-Rad Laboratories, Inc., MiRXES Pte Ltd., Abcam plc, Takara Bio Inc., Quantabio, Horizon Discovery Ltd., NanoString., BioGenex, SeqMatic LLC, GenoSensor, LLC, OriGene Technologies, Inc., System Biosciences, LLC. , HTG Molecular Diagnostics, Inc., GeneCopoeia, Inc., New England Biolabs, Miltenyi Biotec and/or its affiliates, Applied Biological Materials Inc. (abm), Norgen Biotek Corp., Nanjing Vazyme Biotech Co.,Ltd. 


SKU-

TABLE 1 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 2 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY SERVICES, 2020-2029 (USD MILLION)

TABLE 3 GLOBAL SAMPLE COLLECTION IN MICRORNA REVERSE TRANSCRIPTION MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 4 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 5 GLOBAL RT-QPCR IN MICRORNA REVERSE TRANSCRIPTION MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 6 GLOBAL KITS, REAGENTS AND CONSUMABLES IN MICRORNA REVERSE TRANSCRIPTION MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 7 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 8 GLOBAL MICRORNA REVERSE TRANSCRIPTION MARKET, BY END USER, 2020-2029 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The microRNA Reverse Transcription Market will grow at a CAGR of 16.4% during the forecast period of 2022 to 2029.
The significant factors flourishing the growth of the microRNA Reverse Transcription Market are Increasing Prevalence of Cancer and Neurological Disorder and Increasing Increase in the Early Diagnosis Rate.
The major players operating in the microRNA Reverse Transcription Market are Thermofisher Scientific Inc., Agilent, Illumina, Inc., Merck KgaA, QIAGEN, Bio-Rad Laboratories, Inc., MiRXES Pte Ltd., Abcam plc, Takara Bio Inc., Quantabio, Horizon Discovery Ltd., NanoString., BioGenex, SeqMatic LLC, GenoSensor, LLC, OriGene Technologies, Inc., System Biosciences, LLC. , HTG Molecular Diagnostics, Inc., GeneCopoeia, Inc., New England Biolabs, Miltenyi Biotec and/or its affiliates, Applied Biological Materials Inc. (abm), Norgen Biotek Corp., Nanjing Vazyme Biotech Co.,Ltd.
On the basis of application, the microRNA Reverse Transcription Market is segmented into Cancer, Kidney Disease, Neurological Disease, Cardiovascular Disease, Others.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials